Literature DB >> 8758134

3-Phosphoglycerate dehydrogenase deficiency: an inborn error of serine biosynthesis.

J Jaeken1, M Detheux, L Van Maldergem, M Foulon, H Carchon, E Van Schaftingen.   

Abstract

Serine concentrations were markedly decreased in the cerebrospinal fluid of two brothers with congenital microcephaly, profound psychomotor retardation, hypertonia, epilepsy, growth retardation, and hypogonadism. The youngest boy also had congenital bilateral cataract. Magnetic resonance imaging of the brain showed evidence of dysmyelination. Plasma serine as well as plasma and cerebrospinal fluid glycine concentrations were also decreased but to a lesser extent. Treatment with oral serine in the youngest patient significantly increased cerebrospinal fluid serine and abolished the convulsions. In fibroblasts of both patients, a decreased activity was demonstrated of 3-phosphoglycerate dehydrogenase, the first step of serine biosynthesis (22% and 13% of the mean control value). This is an unusual disorder as the great majority of aminoacidopathies are catabolic defects. It is a severe but potentially treatable inborn error of metabolism that has not been previously reported in man.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8758134      PMCID: PMC1511571          DOI: 10.1136/adc.74.6.542

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

1.  Amino acid assignment to one of three blood-brain barrier amino acid carriers.

Authors:  W H Oldendorf; J Szabo
Journal:  Am J Physiol       Date:  1976-01

2.  Enzymic imbalance in serine metabolism in rat hepatomas.

Authors:  K Snell; G Weber
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

3.  Mechanisms of inhibition and activation of beef liver D-glycerate dehydrogenase by inorganic anions.

Authors:  E Sugimoto; Y Kitagawa; M Hirose; H Chiba
Journal:  J Biochem       Date:  1972-12       Impact factor: 3.387

4.  Phosphoserine phosphatase distribution in normal and neoplastic rat tissues.

Authors:  W E Knox; A Herzfeld; J Hudson
Journal:  Arch Biochem Biophys       Date:  1969-07       Impact factor: 4.013

5.  Mouse brain phosphoserine phosphohydrolase and phosphotransferase.

Authors:  W F Bridgers
Journal:  J Biol Chem       Date:  1967-05-10       Impact factor: 5.157

6.  Uptake of individual amino acids by the human brain.

Authors:  P Felig; J Wahren; G Ahlborg
Journal:  Proc Soc Exp Biol Med       Date:  1973-01

7.  Enzymes of serine metabolism in normal and neoplastic rat tissues.

Authors:  K Snell
Journal:  Biochim Biophys Acta       Date:  1985-12-13

8.  Enzymes of serine metabolism in normal, developing and neoplastic rat tissues.

Authors:  K Snell
Journal:  Adv Enzyme Regul       Date:  1984

9.  THE OXIDATION OF D- AND L-GLYCERATE BY RAT LIVER.

Authors:  P D DAWKINS; F DICKENS
Journal:  Biochem J       Date:  1965-02       Impact factor: 3.857

10.  Familial microcephaly with severe neurological deficits: a description of five affected siblings.

Authors:  V Gross-Tsur; A Joseph; G Blinder; N Amir
Journal:  Clin Genet       Date:  1995-01       Impact factor: 4.438

View more
  47 in total

1.  Mutations affecting the development of the peripheral nervous system in Drosophila: a molecular screen for novel proteins.

Authors:  S N Prokopenko; Y He; Y Lu; H J Bellen
Journal:  Genetics       Date:  2000-12       Impact factor: 4.562

2.  Phosphoserine phosphatase deficiency in a patient with Williams syndrome.

Authors:  J Jaeken; M Detheux; J P Fryns; J F Collet; P Alliet; E Van Schaftingen
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

3.  3-Phosphoglycerate dehydrogenase deficiency and 3-phosphoserine phosphatase deficiency: inborn errors of serine biosynthesis.

Authors:  J Jaeken; M Detheux; L Van Maldergem; J P Frijns; P Alliet; M Foulon; H Carchon; E Van Schaftingen
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  A yeast-based complementation assay elucidates the functional impact of 200 missense variants in human PSAT1.

Authors:  Amy Sirr; Russell S Lo; Gareth A Cromie; Adrian C Scott; Julee Ashmead; Mirutse Heyesus; Aimée M Dudley
Journal:  J Inherit Metab Dis       Date:  2020-02-27       Impact factor: 4.982

Review 5.  SPTAN1 encephalopathy: distinct phenotypes and genotypes.

Authors:  Jun Tohyama; Mitsuko Nakashima; Shin Nabatame; Ch'ng Gaik-Siew; Rie Miyata; Zvonka Rener-Primec; Mitsuhiro Kato; Naomichi Matsumoto; Hirotomo Saitsu
Journal:  J Hum Genet       Date:  2015-01-29       Impact factor: 3.172

6.  D-serine influences synaptogenesis in a p19 cell model.

Authors:  Sabine A Fuchs; Martin W Roeleveld; Leo W J Klomp; Ruud Berger; Tom J de Koning
Journal:  JIMD Rep       Date:  2012-02-01

7.  Vitamin B6 is essential for serine de novo biosynthesis.

Authors:  Rúben J Ramos; Mia L Pras-Raves; Johan Gerrits; Maria van der Ham; Marcel Willemsen; Hubertus Prinsen; Boudewijn Burgering; Judith J Jans; Nanda M Verhoeven-Duif
Journal:  J Inherit Metab Dis       Date:  2017-08-11       Impact factor: 4.982

8.  Neu-Laxova syndrome, an inborn error of serine metabolism, is caused by mutations in PHGDH.

Authors:  Ranad Shaheen; Zuhair Rahbeeni; Amal Alhashem; Eissa Faqeih; Qi Zhao; Yong Xiong; Agaadir Almoisheer; Sarah M Al-Qattan; Halima A Almadani; Noufa Al-Onazi; Badi S Al-Baqawi; Mohammad Ali Saleh; Fowzan S Alkuraya
Journal:  Am J Hum Genet       Date:  2014-05-15       Impact factor: 11.025

9.  Neutral amino acid transporter ASCT1 is preferentially expressed in L-Ser-synthetic/storing glial cells in the mouse brain with transient expression in developing capillaries.

Authors:  Kazuhisa Sakai; Hidemi Shimizu; Tatsuro Koike; Shigeki Furuya; Masahiko Watanabe
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

Review 10.  L-serine in disease and development.

Authors:  Tom J de Koning; Keith Snell; Marinus Duran; Ruud Berger; Bwee-Tien Poll-The; Robert Surtees
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.